Biomarkers: an important tool in the characterization of dementia

Ian McKeith

Ian McKeith, FMedSci, MD, FRSB, FRCPsych from Newcastle University, Newcastle, UK talks to us the importance of biomarkers in the characterization of patients suffering from dementia, and discusses a common misunderstanding about their use for this purpose. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.

Share this video  
Similar topics
Related videos
1:41
Progress in developing novel drugs for the treatment of dementia
John Skidmore
2:05
A major theme emerging at the AAIC
Bradford Dickerson
1:37
Keeping a positive attitude against Alzheimer’s disease
Christine Van Broeckhoven
1:23
Share the Orange for Alzheimer’s research
Hilary Evans
1:46
The diversity of non-drug-based interventions against dementia
Séverine Samson
Alzheimer’s Disease, Dementia, Dementia with Lewy Bodies
AAIC 2017
Interview
More from Ian McKeith
Making HEADWAY into research for DLB
Guidelines for the diagnosis of DLB
The content of VJDementia is intended for healthcare professionals